- New School Lunch Rules Target Added Sugars, Salt
- Dairy Cows Moved Across State Lines Must Now Be Tested for Bird Flu
- TikTok Riddled With Misleading Info on Health: Study
- Emulsifier Chemicals Are Everywhere in Foods. Could They Raise Diabetes Risk?
- Opioids During Pregnancy May Not Raise Psychiatric Risks for Offspring
- Could Heartburn Meds Raise Your Migraine Risk?
- Drug, Alcohol Abuse Goes Untreated in Many Ex-Prisoners
- Watchdog Group Says U.S. Food Recalls Rose Again Last Year
- Genes Could Mix With Pesticide Exposure to Raise Parkinson’s Risk
- Breast Cancer Survivors Face Higher Odds for Second Cancer
New Test Helps Diagnose Intellectual Disability in Children
A new test to help diagnose developmental delays and intellectual disability in children based on genetic abnormalities has been approved by the U.S. Food and Drug Administration.
The Affymetrix CytoScan DX Assay scans the entire genetic code from a blood sample and detects chromosomal variations that can lead to developmental and learning problems in children, the agency said Friday in a news release.
Intellectual disability affects as many as 3 percent of children in the United States, the agency said.
Analysis of 960 blood specimens found the new test was better at detecting chromosomal abnormalities that could lead to intellectual disability than other standard tests, the FDA said.
The new test is produced by Affymetrix Inc., based in Santa Clara, Calif.
More information
Medline Plus has more about intellectual disability.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.